The present invention relates to new compounds of formula I, 1 to pharmaceutical formulations containing the compounds, and to the use of the compounds in the prevention and/or treatment of mGluR5 receptor-mediated disorders.

 
Web www.patentalert.com

< Production of a fermentation product

< Heat-sensitive recording material

> Composite materials

> Organopolysiloxanes and the use thereof in substances that can be cross-linked at room temperature
~ 00225